It has been verified in both clinical cohort (Rosello-Lleti et al., 2007) and animal model (Frangogiannis, 2021; Peng et al., 2015) studies that the Th2 cytokine IL-4 participates in HF progression by promoting myocardial fibrosis. This evidence concerns the gene IL4 and Myocardial fibrosis.